Eevia Health Plc appoints Breko as distributor in DACH countries

Eevia Health Plc, ("Eevia" or "The Company") has appointed Breko GmbH in Bremen, Germany as its new distributor in the territory of Germany (D), Austria (A), and Switzerland (CH), also referred to as DACH countries, as well as for some selected Asian countries.

Eevia Health has appointed Breko GmbH out of Bremen as its new distributor in Germany, Austria, Switzerland, and some selected Asian countries. Breko has a long and robust history and offers a range of ingredient products for the food and beverage industry as well as for food supplements, functional food, and cosmetic products. With over 100 years of industry experience in the wine industry, Breko has developed expertise in polyphenol extract products and organic ingredients for food and supplement applications.

According to an industry report from Mordor intelligence, the Europe Nutraceutical Market size is expected to grow from USD 79.95 billion in 2023 to USD 101.60 billion by 2028, at a CAGR of 4.91% during the forecast period (2023-2028). Germany holds a prominent market share of the total European market with a very wide base of consumer brands and nutraceutical companies. Germany has around 108 million consumers, which makes it the largest retail market in Europe. Consumers in Germany demand high-quality products, including organic and health and wellness products.

Furthermore, due to the high elderly population, the interest in healthy aging and prevention of age-related health issues is growing. According to the World Bank data from 2021, about 21.13% of the population in Europe is above the age of 65. Because of this, the region's requirement for nutraceuticals and functional foods is increasing.  

Eevia and Breko have now joined forces to market polyphenol ingredients to over 700 listed leads and prospects. Last week Eevia arranged a training seminar in Finland for key Breko personnel. The parties see mutual opportunities for the development and marketing of new innovative polyphenol extracts, which will be sold as a branded ingredient to selected customers in the territories. Breko already has relevant sales opportunities, which they think they now will be able to source from Eevia.

"We are very excited to commence our cooperation with the team in Finland. We see significant opportunities for their products in the health ingredient and cosmetic markets. The polyphenol extracts Eevia offers come with an intriguing value proposition and brand," says Wolfgang Loersch, Vice President of Ingredients of Breko.

Stein Ulve, CEO and founder of Eevia Health also commented: "Breko stands out as a unique player and much more than a distributor with the strong competence and focus on polyphenols. Their technical understanding of polyphenols is excellent. Breko offers real value to clients in their territory. We look forward to working with Breko in exploring growth opportunities in polyphenol extracts in the next few years."

For further information, please contact:
Stein Ulve, CEO, Eevia Health Plc
Email: [email protected]
Telephone: +358 400 22 5967

Wolfgang Loersch, Vice President Breko GmbH
 Email: [email protected] 
 Telephone: +49 170 630 46 23


Eevia Health Plc, founded in March 2017, addresses significant health problems with bioactive compounds extracted from plant materials. The materials are primarily wild harvested from the pristine Finnish and Swedish forests near or above the Arctic Circle. The extracts are sold B2B as ingredients in dietary supplements and food brands globally. These global brands utilize the ingredients in their consumer product formulas.

Eevia Health is a manufacturer of 100% organically certified plant extracts. Although a significant product, Elderberry extract, is made from cultivated berries, most of Eevia's other raw materials, such as bilberry, lingonberry, chaga-mushroom, and pine bark, are wild-harvested sustainably.

Eevia Health operates a modern green-chemistry production facility in Finland. Manufacturing natural ingredients near the raw material harvest areas, Eevia offers a short value chain with an environmentally friendly carbon footprint, competitive pricing, and extreme transparency. Eevia listed its shares at the Spotlight Stock Market in Sweden in June 2021, with the short name (ticker) EEVIA.

To learn more, please visit or follow Eevia Health on LinkedIn@EeviaHealth. 

Om Eevia Health

Eevia Health targets health problems with bioactive extracts from plant material. The human body has an incredible ability to restore good health. However, sometimes the body needs active support. Our mission is to support good health and well-being with plant extracts which have scientifically documented health benefits. Eevia Health manufactures and markets organic ingredients from abundant plant material in the Arctic. Our products are targeted against low-grade inflammation, problems in eye and brain health, and metabolic effects. We collaborate with scientists in Finland and abroad to scientifically substantiate the positive effects of ingredients and also to document the safety of use.



Kurs ()
Förändring ()
Marknad Spotlight stock market Kortnamn EEVIA ISIN-kod FI4000496658


Stein Ulve IR-kontakt [email protected]